What is he best known for?
The fields of study he is best known for:
Pierre Roques mainly focuses on Virology, Immunology, Virus, Chikungunya and Simian immunodeficiency virus.
His Virology research includes elements of Genetic analysis, Epidemiology and Lymph.
All of his Immunology and Viral load and Immune system investigations are sub-components of the entire Immunology study.
His Virus research is multidisciplinary, incorporating perspectives in Cytoplasm, Nuclear localization sequence, Antibody and Transfection.
He has researched Chikungunya in several fields, including Alphavirus, Viremia and Disease.
His research in Simian immunodeficiency virus intersects with topics in T cell, Phylogeography, Genus and Viral replication.
His most cited work include:
- Identification of a new human immunodeficiency virus type 1 distinct from group M and group O (493 citations)
- Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response (403 citations)
- Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages (367 citations)
What are the main themes of his work throughout his whole career to date?
Virology, Virus, Immunology, Chikungunya and Viral load are his primary areas of study.
Pierre Roques studied Virology and Antibody that intersect with Rheumatoid arthritis.
Pierre Roques focuses mostly in the field of Virus, narrowing it down to matters related to Transmission and, in some cases, Natural history and Pregnancy.
His work focuses on many connections between Chikungunya and other disciplines, such as Disease, that overlap with his field of interest in Alphavirus infection.
His Viral load research incorporates elements of RNA, Sex organ and Genotype.
His biological study spans a wide range of topics, including Peripheral blood mononuclear cell, Antigen and Zidovudine.
He most often published in these fields:
- Virology (75.66%)
- Virus (46.05%)
- Immunology (38.82%)
What were the highlights of his more recent work (between 2016-2020)?
- Virology (75.66%)
- Virus (46.05%)
- Chikungunya (19.08%)
In recent papers he was focusing on the following fields of study:
Pierre Roques mostly deals with Virology, Virus, Chikungunya, Antibody and Viral replication.
Pierre Roques integrates several fields in his works, including Virology and Synonymous substitution.
He is interested in Viral entry, which is a branch of Virus.
The Chikungunya study which covers In vivo that intersects with Viremia, Chloroquine, Alphavirus and Polyarthritis.
His Antibody research incorporates themes from Tumor necrosis factor alpha, Adenosine, Methotrexate and Rheumatoid arthritis.
The concepts of his Viral replication study are interwoven with issues in Togaviridae, Ross River virus and Dengue virus.
Between 2016 and 2020, his most popular works were:
- Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection. (77 citations)
- Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes. (51 citations)
- Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes. (51 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Virus, Virology, Viral entry, Chikungunya and Hepatitis B virus.
His Viral entry research includes themes of Togaviridae, Viral life cycle and Dengue virus.
His Chikungunya study is focused on Immunology in general.
His work in the fields of Interferon overlaps with other areas such as IRGs, Granzyme and Granzyme A.
His Hepatitis B virus research is multidisciplinary, relying on both Viral pathogenesis, Host factor, Viral vector and Macaque.
His study in Viral load is interdisciplinary in nature, drawing from both Arthritis, Viremia, Immune system, Chloroquine and In vivo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
